Mirvetuximab soravtansine (IMGN853) is an antibody-drug coupling (ADC) targeting folate receptor alpha (FRalpha), which inhibits cell growth and enhances the antiproliferative effects of DNA damage, and may be useful in the study of drug-resistant ovarian cancer.
Purity:
90.53%
CAS Number:
[1453084-37-1]
Target:
Antifolate
T77825
* VAT and and shipping costs not included. Errors and price changes excepted